Characterization of Serogroup A Neisseria meningitidis from Invasive Meningococcal Disease Cases in Canada Between 1979 and 2006: Epidemiological Links to Returning Travellers
INTRODUCTION: Serogroup A Neisseria meningitidis has repeatedly caused epidemics of invasive meningococcal disease (IMD) in developing nations since the 1960s. The present study is the first detailed study of serogroup A bacteria isolated in Canada.
Saved in:
Main Authors: | Angela M Sloan, Averil M Henderson, Raymond SW Tsang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2008/523021 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential Capsule Switching from Serogroup Y to B: The Characterization of Three such Neisseria meningitidis Isolates Causing Invasive Meningococcal Disease in Canada
by: Raymond SW Tsang, et al.
Published: (2005-01-01) -
Profile of Serogroup Y Meningococcal Infections in Canada: Implications for Vaccine Selection
by: Nicole Le Saux, et al.
Published: (2009-01-01) -
Genetic and Antigenic Analysis of Invasive Serogroup C Neisseria meningitidis in Canada: A Decrease in the Electrophoretic Type (Et)-15 Clonal Type and an Increase in the Proportion of Isolates Belonging to the Et-37 (But Not Et-15) Clonal Type During the Period from 2002 to 2009
by: Jianwei Zhou, et al.
Published: (2012-01-01) -
Epidemiological Characteristics of Meningococcal Meningitis (2016 to 2018) Four Years after the Introduction of Serogroup A Meningococcal Conjugate Vaccine in Benin
by: Togbemabou Primous Martial Godjedo, et al.
Published: (2020-01-01) -
Are Physicians Obligated to Tell Parents about the Meningococcal Serogroup B Vaccine?
by: Dr Joan L Robinson
Published: (2015-01-01)